INPP5D gene therapy (NYU Langone Health)

N/A

Report date: 2025/01/26 19:32:23

Base Information

Drug NameINPP5D gene therapy (NYU Langone Health)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 modulators
TargetsPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNyu Langone Health
China Registration ClassN/A

Develop Information

Active CompaniesNyu Langone Health
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A